ETAP-Lab renews its ISO 9001 certification: Your assurance of quality, reliability and customer satisfaction
We are delighted to announce the renewal of ETAP-Lab's ISO 9001 certification. This achievement underlines our commitment to providing exemplary preclinical research services. A commitment to quality and customer satisfaction Our robust quality management system, backed by our ISO9001 certification, ensures to our customers: compliance with rigorous quality standards: we follow established protocols and guidelines to ensure the accuracy and reliability of our services. Continuous improvement: We constantly focus on improving our processes and services, driven by a commitment to excellence. Customer-focused
Join us at the 16th World Stroke Congress in Abu Dhabi this October!
🌍ETAP-Lab is happy to present a poster at the 16th World Stroke Congress (WSC 2024) in Abu Dhabi, UAE, from October 23-26, 2024 organized by the World Stroke Organization.  ETAP-Lab's team is looking forward to attending this global event that explores "the forefront of stroke and cerebrovascular disease topics and present the most influential late breaking clinical trials". As a preclinical efficacy CRO, ETAP-Lab will unveil its poster on original preclinical results about in vivo assays on Stroke disease. The results presented
IBD Research – ETAP-Labs and Kisolite Corp enter into partnership.
Better than any certification, at ETAP-Lab we believe that customer recognition is the ultimate goal. We're proud to announce our strategic partnership with Kisolite Corp, a leader in innovative therapeutic solutions. Together, we're advancing in vivo studies for their treatment targeting Inflammatory Bowel Disease (IBD). Our dedication to building lasting relationships goes beyond expertise. Our flexible and human-sized organization offers personalized support, ensuring clients feel empowered throughout the research process. Ready to collaborate on your next drug efficacy study? Contact us today